255 related articles for article (PubMed ID: 29034206)
1. Leukemia-Initiating Cells in T-Cell Acute Lymphoblastic Leukemia.
Tan SH; Bertulfo FC; Sanda T
Front Oncol; 2017; 7():218. PubMed ID: 29034206
[TBL] [Abstract][Full Text] [Related]
2. Targeting signaling pathways in T-cell acute lymphoblastic leukemia initiating cells.
Martelli AM; Lonetti A; Buontempo F; Ricci F; Tazzari PL; Evangelisti C; Bressanin D; Cappellini A; Orsini E; Chiarini F
Adv Biol Regul; 2014 Sep; 56():6-21. PubMed ID: 24819383
[TBL] [Abstract][Full Text] [Related]
3. Targeting Leukemia-Initiating Cells in Acute Lymphoblastic Leukemia.
Tamiro F; Weng AP; Giambra V
Cancer Res; 2021 Aug; 81(16):4165-4173. PubMed ID: 33414170
[TBL] [Abstract][Full Text] [Related]
4. Expression of CD34 and CD7 on human T-cell acute lymphoblastic leukemia discriminates functionally heterogeneous cell populations.
Gerby B; Clappier E; Armstrong F; Deswarte C; Calvo J; Poglio S; Soulier J; Boissel N; Leblanc T; Baruchel A; Landman-Parker J; Roméo PH; Ballerini P; Pflumio F
Leukemia; 2011 Aug; 25(8):1249-58. PubMed ID: 21566655
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic transcriptional program driven by TAL1 in T-cell acute lymphoblastic leukemia.
Tan TK; Zhang C; Sanda T
Int J Hematol; 2019 Jan; 109(1):5-17. PubMed ID: 30145780
[TBL] [Abstract][Full Text] [Related]
6. Hypoxic, glycolytic metabolism is a vulnerability of B-acute lymphoblastic leukemia-initiating cells.
Morris V; Wang D; Li Z; Marion W; Hughes T; Sousa P; Harada T; Sui SH; Naumenko S; Kalfon J; Sensharma P; Falchetti M; Vinicius da Silva R; Candelli T; Schneider P; Margaritis T; Holstege FCP; Pikman Y; Harris M; Stam RW; Orkin SH; Koehler AN; Shalek AK; North TE; Pimkin M; Daley GQ; Lummertz da Rocha E; Rowe RG
Cell Rep; 2022 Apr; 39(4):110752. PubMed ID: 35476984
[TBL] [Abstract][Full Text] [Related]
7. TAL1 as a master oncogenic transcription factor in T-cell acute lymphoblastic leukemia.
Sanda T; Leong WZ
Exp Hematol; 2017 Sep; 53():7-15. PubMed ID: 28652130
[TBL] [Abstract][Full Text] [Related]
8. Noncanonical β-catenin interactions promote leukemia-initiating activity in early T-cell acute lymphoblastic leukemia.
Panelli P; De Santis E; Colucci M; Tamiro F; Sansico F; Miroballo M; Murgo E; Padovano C; Gusscott S; Ciavarella M; Chavez EA; Bianchi F; Rossi G; Carella AM; Steidl C; Weng AP; Giambra V
Blood; 2023 Mar; 141(13):1597-1609. PubMed ID: 36315912
[TBL] [Abstract][Full Text] [Related]
9. Stem Cell Hierarchy and Clonal Evolution in Acute Lymphoblastic Leukemia.
Lang F; Wojcik B; Rieger MA
Stem Cells Int; 2015; 2015():137164. PubMed ID: 26236346
[TBL] [Abstract][Full Text] [Related]
10. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
Hales EC; Taub JW; Matherly LH
Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
[TBL] [Abstract][Full Text] [Related]
11. CD274 promotes cell cycle entry of leukemia-initiating cells through JNK/Cyclin D2 signaling.
Fang X; Chen C; Xia F; Yu Z; Zhang Y; Zhang F; Gu H; Wan J; Zhang X; Weng W; Zhang CC; Chen GQ; Liang A; Xie L; Zheng J
J Hematol Oncol; 2016 Nov; 9(1):124. PubMed ID: 27855694
[TBL] [Abstract][Full Text] [Related]
12. T cell acute lymphoblastic leukemia/lymphoma: a human cancer commonly associated with aberrant NOTCH1 signaling.
Pear WS; Aster JC
Curr Opin Hematol; 2004 Nov; 11(6):426-33. PubMed ID: 15548998
[TBL] [Abstract][Full Text] [Related]
13. The NOTCH1/CD44 axis drives pathogenesis in a T cell acute lymphoblastic leukemia model.
García-Peydró M; Fuentes P; Mosquera M; García-León MJ; Alcain J; Rodríguez A; García de Miguel P; Menéndez P; Weijer K; Spits H; Scadden DT; Cuesta-Mateos C; Muñoz-Calleja C; Sánchez-Madrid F; Toribio ML
J Clin Invest; 2018 Jul; 128(7):2802-2818. PubMed ID: 29781813
[TBL] [Abstract][Full Text] [Related]
14. Targeting Leukemia-Initiating Cells and Leukemic Niches: The Next Therapy Station for T-Cell Acute Lymphoblastic Leukemia?
Zhang Z; Yang K; Zhang H
Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428753
[TBL] [Abstract][Full Text] [Related]
15. SCL, LMO1 and Notch1 reprogram thymocytes into self-renewing cells.
Gerby B; Tremblay CS; Tremblay M; Rojas-Sutterlin S; Herblot S; Hébert J; Sauvageau G; Lemieux S; Lécuyer E; Veiga DF; Hoang T
PLoS Genet; 2014 Dec; 10(12):e1004768. PubMed ID: 25522233
[TBL] [Abstract][Full Text] [Related]
16. FOXP3 can modulate TAL1 transcriptional activity through interaction with LMO2.
Fleskens V; Mokry M; van der Leun AM; Huppelschoten S; Pals CE; Peeters J; Coenen S; Cardoso BA; Barata JT; van Loosdregt J; Coffer PJ
Oncogene; 2016 Aug; 35(31):4141-8. PubMed ID: 26686090
[TBL] [Abstract][Full Text] [Related]
17. The clinical significance of monitoring the expression of the SIL-TAL1 fusion gene in T-cell acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation.
Zhao X; Hong Y; Qin Y; Xu Y; Chang Y; Wang Y; Zhang X; Xu L; Huang X
Int J Lab Hematol; 2017 Dec; 39(6):613-619. PubMed ID: 28736882
[TBL] [Abstract][Full Text] [Related]
18. Aberrant activation of the GIMAP enhancer by oncogenic transcription factors in T-cell acute lymphoblastic leukemia.
Liau WS; Tan SH; Ngoc PCT; Wang CQ; Tergaonkar V; Feng H; Gong Z; Osato M; Look AT; Sanda T
Leukemia; 2017 Aug; 31(8):1798-1807. PubMed ID: 28028313
[TBL] [Abstract][Full Text] [Related]
19. [Understanding of molecular pathogenesis of T-cell leukemia by super-enhancer profiling].
Sanda T
Rinsho Ketsueki; 2018; 59(7):899-908. PubMed ID: 30078801
[TBL] [Abstract][Full Text] [Related]
20. Preleukemia and Leukemia-Initiating Cell Activity in inv(16) Acute Myeloid Leukemia.
Pulikkan JA; Castilla LH
Front Oncol; 2018; 8():129. PubMed ID: 29755956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
